"Targeting the Prefrontal Cortex and Cognition for Intervention in Addiction”
William K. Warren, Jr. Frontiers in Neuroscience Lecture
Laureate Psychiatric Clinic and Hospital Conference Center
11:00am - 11:45 pm Registration and Lunch
12:00pm - 1:00 pm Program
Dr. Goldstein is a Professor of Psychiatry with a secondary appointment in the Department of Neuroscience at the Icahn School of Medicine at Mount Sinai (ISMMS) in NY. Dr. Goldstein is chief of the Brain Imaging Center (BIC) at ISMMS; she also directs the NARC (Neuropsychoimaging of Addiction and Related Conditions) research group that uses multimodality functional neuroimaging methods to explore the neurobiological basis of impaired cognitive and emotional functioning in human drug addiction and other disorders of self-control. An important application of this research is to facilitate the development of intervention modalities that would improve treatment outcome in drug addiction and other chronically relapsing disorders of self-regulation. Nationally and internationally known for her neuroimaging and neuropsychological studies in drug addiction, Dr. Goldstein formulated a theoretical model known as Impaired Response Inhibition and Salience Attribution (iRISA). The model uses multiple neuroimaging modalities—including MRI, EEG/ERP, PET—and neuropsychological tests to explore the neurobiological underpinnings of iRISA in drug addiction and related conditions. Dr. Goldstein became fellow of the American College of Neuropsychopharmacology (ACNP) in January 2015, receiving the prestigious Joel Elkes Research Award in 2012 and the Jacob P. Waletzky Award in 2013.
Learning points:
1. Identify the core neuropsychological mechanisms (response inhibition, salience attribution, and self-awareness/insight into illness) underlying the clinical symptomatology of drug addiction
2. Recognize the contribution of compromises in brain function and structure to human cocaine addiction
3. Is there recovery of brain function and structure in addiction?
For Physicians: CME credit will be given.
For Psychologists: The Oklahoma State Board of Examiners of Psychologists, the American Psychological Association and the Oklahoma Psychological Association recognizes AMA PRA Category 1 credit™.
For Social Workers: This event has been approved by the Oklahoma State Board of Licensed Social Workers for 1 hour Category 1Clinical. (CEP Number - 20150007)
For LPCs and LMFTs: An application has been made to the State Board of Behavioral Health Licensure (BBHL) for 1 hour of CE.
For CADCs and LADCs: Laureate Psychiatric Clinic and Hospital, Tulsa, Oklahoma, is accredited as a provider of continuing chemical dependency education by the State of Oklahoma - Board of Licensed Alcohol and Drug Counselors for 1 hour of CE.
REGISTER TO ATTEND!
Email: Lauren Haguewood at lehaguewood@saintfrancis.com
William K. Warren, Jr. Frontiers in Neuroscience Lecture
Laureate Psychiatric Clinic and Hospital Conference Center
11:00am - 11:45 pm Registration and Lunch
12:00pm - 1:00 pm Program
Dr. Goldstein is a Professor of Psychiatry with a secondary appointment in the Department of Neuroscience at the Icahn School of Medicine at Mount Sinai (ISMMS) in NY. Dr. Goldstein is chief of the Brain Imaging Center (BIC) at ISMMS; she also directs the NARC (Neuropsychoimaging of Addiction and Related Conditions) research group that uses multimodality functional neuroimaging methods to explore the neurobiological basis of impaired cognitive and emotional functioning in human drug addiction and other disorders of self-control. An important application of this research is to facilitate the development of intervention modalities that would improve treatment outcome in drug addiction and other chronically relapsing disorders of self-regulation. Nationally and internationally known for her neuroimaging and neuropsychological studies in drug addiction, Dr. Goldstein formulated a theoretical model known as Impaired Response Inhibition and Salience Attribution (iRISA). The model uses multiple neuroimaging modalities—including MRI, EEG/ERP, PET—and neuropsychological tests to explore the neurobiological underpinnings of iRISA in drug addiction and related conditions. Dr. Goldstein became fellow of the American College of Neuropsychopharmacology (ACNP) in January 2015, receiving the prestigious Joel Elkes Research Award in 2012 and the Jacob P. Waletzky Award in 2013.
Learning points:
1. Identify the core neuropsychological mechanisms (response inhibition, salience attribution, and self-awareness/insight into illness) underlying the clinical symptomatology of drug addiction
2. Recognize the contribution of compromises in brain function and structure to human cocaine addiction
3. Is there recovery of brain function and structure in addiction?
For Physicians: CME credit will be given.
For Psychologists: The Oklahoma State Board of Examiners of Psychologists, the American Psychological Association and the Oklahoma Psychological Association recognizes AMA PRA Category 1 credit™.
For Social Workers: This event has been approved by the Oklahoma State Board of Licensed Social Workers for 1 hour Category 1Clinical. (CEP Number - 20150007)
For LPCs and LMFTs: An application has been made to the State Board of Behavioral Health Licensure (BBHL) for 1 hour of CE.
For CADCs and LADCs: Laureate Psychiatric Clinic and Hospital, Tulsa, Oklahoma, is accredited as a provider of continuing chemical dependency education by the State of Oklahoma - Board of Licensed Alcohol and Drug Counselors for 1 hour of CE.
REGISTER TO ATTEND!
Email: Lauren Haguewood at lehaguewood@saintfrancis.com
RSS Feed
